Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > How many patients do they plan to treat in this phase of res

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon Dec 01, 2022 8:45pm

210 Views

Post# 35145075

RE:How many patients do they plan to treat in this phase of res

Eddy,

Probably the most intelligent question you asked . No at the current burn rate they will run out of money before end of 2024. Fda clinical trials won't start in 2025 because Uncke Phil will have no cash .
But that's ok he's got a comfy couch for another two years or 2 weeks ......

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs